Reduction of angiotensin II in the cerebrospinal fluid of patients with multiple sclerosis

Abstract

We previously demonstrated that angiotensin II acts as a crucial neuroprotective factor after neural injury through angiotensin II type-2 (AT2) receptor signaling. Although the pathway is known to play an important role in the development of experimental autoimmune encephalomyelitis, cerebrospinal fluid (CSF) angiotensin II levels in patients with multiple sclerosis (MS) have never been studied. To clarify the significance of angiotensin II in MS, we assayed angiotensin II concentrations using an established enzyme-linked immunoabsorbent assay in CSF samples from patients with MS (n = 21), patients with inflammatory neuropathies (IN) (n = 23) and control individuals who did not have either of the neurological diseases or any other disease that might affect the angiotensin II levels in the CSF (control) (n = 24). Angiotensin II levels in the CSF were 3.79 ± 1.54 pg/ml in the MS group, 5.13 ± 2.27 pg/ml in the IN group and 6.71 ± 2.65 pg/ml in the control group. The angiotensin II levels in the CSF of the MS group were significantly lower than in the control group (p = 0.00057). Angiotensin II concentration in the CSF tended to have a negative correlation with the Kurtzke’s Expanded Disability Status Scale scores during MS relapse (p = 0.0847). These findings suggest that reduced levels of intrathecal angiotensin II may be related to the abnormal neural damage and repair processes in MS.

Keywords

angiotensin II multiple sclerosis cerebrospinal fluid

Get full access to this article

View all access options for this article.

References

1 Shao J Nangaku M Miyata T Inagi R Yamada K Kurokawa K . Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 2003; 42: 31 – 38 .

2 Constantinescu CS Ventura E Hilliard B Rostami A . Effects of the angiotensin converting enzyme inhibitor captopril on experimental autoimmune encephalomyelitis. Immunopharmacol Immunotoxicol 1995; 17: 471 – 491 .

3 Mogi M Li JM Iwanami J Min LJ Tsukuda K Iwai M . Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2. Hypertension 2006; 48: 141 – 148 .

4 Li JM Mogi M Tsukuda K Tomochika H Iwanami J Min LJ . Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1. Mol Endocrinol 2007; 21: 499 – 511 .

5 Asbury AK Cornblath DR . Assessment of current diagnostic criteria for Guillain–Barré syndrome. Review. Ann Neurol 1990; 27: S21 – S24 .

6 Ad Hoc American Academy of Neurology AIDS Task Force . Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy. Neurology 1991; 41: 617 – 618 .

7 Poser CM Paty DW Scheingerg L McDonald WI Davis FA Ebers GC . New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227 – 231 .

8 McDonald WI Compston A Edan G Goodkin D Hartung HP Lublin FD . Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50: 121 – 127 .

9 Kira J Kanai T Nishimura Y Yamasaki K Matsushita S Kawano Y . Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996; 40: 569 – 574 .

10.

10 Kurtzke JF . Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444 – 1452 .

11.

11 Dalla Libera L Ravara B Angelini A Rossini K Sandri M Thiene G . Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure. Circulation 2001; 103: 2195 – 2200 .

12.

12 Finkielman S Fischer-Ferraro C Diaz A Goldstein DJ Nahmod VE . A pressor substance in the cerebrospinal fluid of normotensive and hypertensive patients. Proc Natl Acad Sci U S A 1972; 69: 3341 – 3344 .

13.

13 Vervoort VS Beachem MA Edwards PS Ladd S Miller KE de Mollerat X . AGTR2 mutations in X-linked mental retardation. Science 2002; 296: 2401 – 2403 .

14.

14 Okuyama S Sakagawa T Chiaki S Imagawa Y Ichiki T Inagami T . Anxiety-like behavior in mice lacking the angiotensin II type-2 receptor. Brain Res 1999; 821: 150 – 159 .